This article first appeared on GuruFocus.

Release Date: November 06, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Nutrien Ltd (NYSE:NTR) delivered structural earnings growth through record upstream fertilizer sales volumes and improved reliability.

The company raised its 2025 potash sales volumes guidance range for the second time this year.

Nutrien Ltd (NYSE:NTR) achieved a 94% ammonia utilization rate, up 7% points from the previous year.

The company is on track to achieve its $200 million cost reduction target one year ahead of schedule.

Nutrien Ltd (NYSE:NTR) allocated $1.2 billion to dividends and share repurchases in the first nine months, representing a 42% increase from the prior year.

Nutrien Ltd (NYSE:NTR) completed a controlled shutdown of its Trinidad nitrogen operations due to uncertainty with respect to port access and a lack of reliable and economic gas supply.

The phosphate business only contributes about 6% of EBITDA, prompting a strategic review.

The company is facing challenges in the ammonia markets due to plant outages and project delays.

Nutrien Ltd (NYSE:NTR) lowered capital expenditures by 10% on a year-to-date basis, which may impact future growth investments.

The Trinidad operations were projected to account for approximately 1% of consolidated free cash flow in 2025, a contribution that has been under pressure for an extended period of time.

Warning! GuruFocus has detected 4 Warning Signs with NTR.

Is NTR fairly valued? Test your thesis with our free DCF calculator.

Q: How does the cash generation of the phosphate business compare to the rest of Nutrien's operations, and what is the strategic review aiming to achieve? A: Ken Seitz, President and CEO, explained that the phosphate business contributes about 6% of Nutrien's EBITDA, prompting a strategic review to enhance earnings quality and free cash flow. The review will explore options like reconfiguring operations, strategic partnerships, or a potential sale, with conclusions expected in 2026.

Q: What initiatives have been undertaken since Mark Thompson became CFO, and how are the 2026 targets tracking? A: Mark Thompson, CFO, highlighted significant progress on strategic initiatives, including a projected 1.4 million tons increase in upstream fertilizer sales and $300 million growth in retail EBITDA. Nutrien is ahead of schedule on a $200 million cost reduction target and has generated $900 million from divesting non-core assets.

Q: Are there other opportunities for non-core asset sales beyond the current strategic reviews? A: Ken Seitz stated that the focus remains on the phosphate business, Trinidad operations, and Brazil improvement plans. While there may be smaller asset divestitures, the primary focus is on these three areas to improve earnings quality and free cash flow.

Q: How is the fall season playing out in terms of crop nutrient demand, and are there any concerns about demand deferral? A: Ken Seitz noted that while nitrogen volumes are expected to rise, potash volumes may remain flat, and phosphate volumes might decrease slightly. Jeff Holtzman added that strong crop yields necessitate nutrient replenishment, with favorable weather supporting robust field activity.

Q: What is Nutrien's strategy for its nitrogen operations, especially considering the Trinidad shutdown? A: Ken Seitz emphasized focusing on reliability improvements and low-capital debottlenecking initiatives to increase nitrogen volumes. While Trinidad's contribution is minimal, Nutrien is exploring options for stable gas supply and port access to optimize operations there.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.